Results for: Disease

November 12, 2018

Research Continues for Work Begun in the Genomics Sequencing Center Summer Program

March 15, 2018

Epigenomic Tool Breakthrough Has Implications for Identifying Disease Processes

Through a collaboration with Virginia Tech chemical engineering experts, Biocomplexity Institute researcher Hehuang "David" Xie has helped simplify the way scientists will identify the epigenetic roots of disease.

October 26, 2017

Virginia Tech Scientists Share Research at Virginia Academy of Science, Engineering, and Medicine

Virginia Tech leaders, scientists, and engineers will gather Oct. 29-30 to focus on challenges in emerging infections and preparedness for the 2017 Summit of the Virginia Academy of Science, Engineering, and Medicine (VASEM). 

July 17, 2017

Precision Medicine Could Help Patients Grappling with Life-threatening Intestinal Infections

Patients in long-term care facilities face an elevated risk of C. difficile infection, a life-threatening disease that could be managed more effectively with a precision medicine treatment plan.

June 20, 2017

Biocomplexity Institute’s Ebola-tested Tools Help Set New Standard for Federal Disease Control

Biocomplexity Institute researchers are building an online network designed to help disease experts share information, identify warning signs of impending epidemics, and coordinate effective response strategies for ongoing outbreaks.

June 15, 2017

Researchers Uncover New Immunometabolic Target for Inflammatory Bowel Disease Treatments

Researchers at the Biocomplexity Institute of Virginia Tech have discovered a new therapeutic target for inflammatory bowel disease, and it’s right inside our immune cells: a gene known as NLRX1.

April 21, 2017

Research Shines Positive Light on Harmful Bacteria

Researchers at the Biocomplexity Institute of Virginia Tech are exploring why H. pylori bacteria are harmful to some people, while providing health benefits to others.

April 06, 2017

Successful Drug Trial Hints at Safer, More Effective Treatments for Flu

With hospitalizations estimated in the hundreds of thousands for influenza, research is more important than ever. Researchers at the Biocomplexity Institute of Virginia Tech’s Nutritional Immunology and Molecular Medicine Laboratory (NIMML) have recently explored a new therapeutic target to treat flu infection.

March 29, 2017

Hopping the Species Barrier: Harmful Bacteria Discovered in Both Amphibians and Mammals

Once thought to affect mainly humans and livestock, Brucella bacteria are now being found in species scientists never expected. Previously unknown strains of the bacteria were recently discovered in African bullfrogs.

December 17, 2015

Lowering Flu Season’s Heavy Toll

As year-end activities ramp up, the flu is in full swing. In a season that’s often filled with social and economic pressures, the added price of influenza can be staggering: up to $87B in medical costs and lost productivity according to the latest Centers for Disease Control (CDC) statistics.

August 04, 2015

PATRIC: Fighting Antibiotic Resistance Worldwide

Antibacterial resistance is becoming an increasingly pressing problem in hospitals around the world. More and more species of bacteria are developing resistances to commonly used antibiotics, forcing an antibacterial arms race that often results in the death of patients.

December 02, 2013

Scientists Aid in Fighting Deadly, Drug-Resistant TB Around the World

BLACKSBURG, Va, December 2, 2013 – Researchers at Virginia Bioinformatics Institute have recently returned from a trip halfway across the globe in the race to confront drug-resistant tuberculosis. As part of a week-long course in comparative genomics organized by researchers from the Broad Institute, senior bioscientist and computational biologist Rebecca Wattam trained participants on using the Pathosystems Resource Integration Center (PATRIC). PATRIC is a web-based portal that provides bacterial infectious disease researchers with analysis tools and comparative data.  The course took place at the Kwazulu-Natal Research Institute for Tuberculosis and HIV (K-RITH) in Durban, South Africa and involved participants from all over Africa.

April 27, 2008

Scientists Reveal Evolutionary Intricacies of Rickettsia Pathogens

BLACKSBURG, Va., April 28, 2008 - Scientists from the Virginia Bioinformatics Institute (VBI) at Virginia Tech and the University of Maryland School of Medicine have unveiled some of the evolutionary intricacies of rickettsial pathogens by analyzing over a decade's worth of genomic data. Some species of Rickettsia are known to cause harmful diseases in humans, such as epidemic typhus (R. prowazekii) and Rocky Mountain spotted fever (R. rickettsii), while others have been identified as emerging pathogens and organisms that might possibly be used for the development of biological weapons. The new data, which are publicly available via the PATRIC project web site, open up exciting new possibilities for future research.